POLYMED

POLY MEDICURE

Mid Cap BSE: 531768 NSE: POLYMED
₹979.7
14.95 (1.55%)
  • Advice
  • Hold
As on 04 December, 2022 | 14:20

Poly Medicure Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in POLY MEDICURE

Start SIP

Poly Medicure Share Price

Poly Medicure Share Returns

  • Over 1 Month 7.91%
  • Over 3 Month 8.92%
  • Over 6 Month 25.67%
  • Over 1 Year -6.74%

Poly Medicure Key Statistics

P/E Ratio 66.6
PEG Ratio -11.3
Market Cap Cr 9,397
Price to Book Ratio 8.6
EPS 14.6
Dividend 0.3
Relative Strength Index 51.56
Money Flow Index 49.87
MACD Signal 10.22
Average True Range 28.72

Poly Medicure Investment Rating

  • Master Rating:
  • Poly Medicure has an operating revenue of Rs. 1,011.34 Cr. on a trailing 12-month basis. An annual revenue growth of 19% is outstanding, Pre-tax margin of 21% is great, ROE of 13% is good. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 16% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 82 which is a GOOD score indicating consistency in earnings, a RS Rating of 56 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 43 indicates it belongs to a fair industry group of Medical-Systems/Equip and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Poly Medicure Financials
IndicatorSep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021
Oper Rev Qtr Cr 264239244220212203203
Operating Expenses Qtr Cr 198191188169161149150
Operating Profit Qtr Cr 66485751505453
Depreciation Qtr Cr 14141413131312
Interest Qtr Cr 011-103-2
Tax Qtr Cr 1691311121313
Net Profit Qtr Cr 45293834373637

Poly Medicure Technicals

EMA & SMA

Current Price
979.7
14.95 (1.55%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • 963.8
  • 50 Day
  • 936.02
  • 100 Day
  • 894.8
  • 200 Day
  • 864.93
  • 20 Day
  • 973.31
  • 50 Day
  • 942.42
  • 100 Day
  • 866.34
  • 200 Day
  • 829.37

Poly Medicure Resistance and Support

PIVOT
₹969.94
Resistance
First Resistance 977.82
Second Resistance 990.89
Third Resistance 998.77
RSI 51.56
MFI 49.87
MACD Single Line 10.23
MACD 7.84
Support
First Resistance 956.87
Second Resistance 948.99
Third Resistance 935.92

Poly Medicure Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 13,757 727,608 52.89
Week 26,549 1,246,466 46.95
1 Month 73,929 2,817,432 38.11
6 Month 70,029 2,546,266 36.36

Poly Medicure Result Highlights

Poly Medicure Synopsis

NSE-Medical-Systems/Equip

Poly Medicure Lt is involved in the business activities of Wholesale of pharmaceutical and medical goods. Company’s Total Operating Revenue is Rs. 879.36 Cr. and Equity Capital is Rs. 47.95 Cr. for the Year ended 31/03/2022. Poly Medicure Ltd. is a Public Limited Listed company incorporated on 30/03/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L40300DL1995PLC066923 and registration number is 066923.
Market Cap 9,246
Sales 967
Shares in Float 4.51
No of funds 94
Yield 0.26
Book Value 8.58
U/D Vol ratio 1
LTDebt / Equity 3
Alpha
Beta 0.5

Poly Medicure

Owner NameSep-22Jun-22Mar-22Dec-21
Promoters 53.33%53.34%44.66%
Mutual Funds 3.03%2.92%2.87%
Insurance Companies 0.18%0.18%0.31%
Foreign Portfolio Investors 16.27%15.59%15.07%
Financial Institutions/ Banks
Individual Investors 11.2%11.93%12.31%
Others 15.99%16.04%24.78%

Poly Medicure Management

Name Designation
Mr. Devendra Raj Mehta Chairman
Mr. Himanshu Baid Managing Director
Mr. Rishi Baid Joint Managing Director
Mr. Jugal Kishore Baid Non Executive Director
Mrs. Mukulika Baid Non Executive Director
Mr. Alessandro Balboni Non Executive Director
Dr. Sandeep Bhargava Ind. Non-Executive Director
Mr. Amit Khosla Ind. Non-Executive Director
Ms. Sonal Mattoo Ind. Non-Executive Director
Mr. Prakash Chand Surana Ind. Non-Executive Director
Dr. Shailendra Raj Mehta Ind. Non-Executive Director
Dr. Ambrish Mithal Additional Director

Poly Medicure Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Poly Medicure Corporate Action

Date Purpose Remarks
2022-11-04 Quarterly Results
2022-08-04 Quarterly Results
2022-05-24 Audited Results & Final Dividend
2022-01-31 Quarterly Results
2021-11-01 Quarterly Results

Poly Medicure MF Shareholding

Name Amount(cr)
UTI Flexi Cap Fund Regular Plan Growth 26133
UTI Unit Linked Insurance 5262
WhiteOak Capital Flexi Cap Fund Regular Growth 841
UTI Healthcare Fund Regular Plan Growth 725
Motilal Oswal Nifty 500 Fund Regular Growth 368

About Company

Poly Medicure FAQs

What is Share Price of Poly Medicure ?

Poly Medicure share price is ₹979 As on 04 December, 2022 | 14:06

What is the Market Cap of Poly Medicure ?

The Market Cap of Poly Medicure is ₹9397.1 Cr As on 04 December, 2022 | 14:06

What is the P/E ratio of Poly Medicure ?

The P/E ratio of Poly Medicure is 66.6 As on 04 December, 2022 | 14:06

What is the PB ratio of Poly Medicure ?

The PB ratio of Poly Medicure is 8.6 As on 04 December, 2022 | 14:06

Q2FY23